Anaplastic large cell lymphoma (ALCL), ALK-negative, is a subtype of non-Hodgkin lymphoma characterized by the proliferation of large, atypical lymphoid cells. This specific variant primarily affects the intrapelvic lymph nodes and is associated with aggressive clinical behavior. Accurate coding with ICD-10 Code C84.76 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this malignancy.
ICD-10 Code C84.76 represents Anaplastic large cell lymphoma, ALK-negative, specifically affecting the intrapelvic lymph nodes. This code is utilized in clinical documentation and billing when diagnosing patients with this aggressive form of lymphoma, which is critical for treatment planning and tracking disease progression.
Anaplastic large cell lymphoma, ALK-negative, is a hematological malignancy that arises from T-cell lineage and is characterized by the presence of large, anaplastic cells. The condition often presents with lymphadenopathy and requires prompt medical intervention due to its aggressive nature. Understanding this diagnosis is crucial for effective management and treatment.
ICD-10 Code C84.76 is integral to SOAP notes, facilitating the documentation of symptoms, assessments, and treatment plans for patients diagnosed with Anaplastic large cell lymphoma, ALK-negative. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C84.76 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-negative. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
The management of Anaplastic large cell lymphoma, ALK-negative, often necessitates hospitalization due to the aggressive nature of the disease. Treatment typically involves chemotherapy and may include targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.76 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77021 | Computed tomography, pelvis, with contrast material. |
Common Questions About Using ICD-10 Code C84.76 for Anaplastic large cell lymphoma, ALK-neg, intrapelv nodes
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and abdominal discomfort due to lymphadenopathy.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of anaplastic cells.
What treatment options are available for Anaplastic large cell lymphoma?
Treatment usually includes chemotherapy, and in some cases, targeted therapies may be considered. Supportive care is also important to manage symptoms and side effects.
How does ICD-10 Code C84.76 impact billing?
ICD-10 Code C84.76 is essential for accurate billing and reimbursement for services related to the diagnosis and treatment of Anaplastic large cell lymphoma, ensuring compliance with healthcare regulations.
Clinical Notes
SOAP notes
DAP notes
AI medical notes